[1]
“Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study”, Kathmandu Univ. Med. J., vol. 19, no. 2, pp. 243–247, Jun. 2021, doi: 10.3126/kumj.v19i2.49655.